Calton & Associates’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-500
Closed -$28K – 1343
2017
Q4
$28K Buy
+500
New +$29.2K 0.01% 823

Other funds holding SGEN

Calton & Associates's SGEN Position: Q1 2018 in Review

Calton & Associates sold out of Seagen Inc. Common Stock (SGEN) in Q1 2018, closing a stake of 500 shares — an estimated $28K sold.

Calton & Associates first reported a position in SGEN in Q4 2017 and held it in 1 quarter. The position peaked at $28K in Q4 2017. 287 funds tracked by Wall St. Rank hold SGEN as of Q1 2018.

  • Calton & Associates reported no remaining Seagen Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 500 Seagen Inc. Common Stock shares in Q1 2018, an estimated $28K.
  • Calton & Associates first reported a position in Seagen Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Seagen Inc. Common Stock position peaked at $28K in Q4 2017.
  • 287 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.